Clinical Trial Update: MOM NEST Study: Maternal Opioid Medication: Naltrexone Efficacy Study

View source ↗

Summary

The MOM NEST trial evaluating the efficacy of naltrexone for maternal opioid use disorder and neonatal abstinence syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Use Disorder
• High-risk Pregnancy
• Neonatal Abstinence Syndrome
• Opioid Use Disorder

Drugs mentioned

• Naltrexone (Naltrexone)

Snippet

Sponsor: Boston Medical Center | Conditions: Opioid-use Disorder, Neonatal Abstinence Syndrome | Status: COMPLETED